Ambulatory Long Length Urodynamics Evaluation with Glean Urodynamics System
This study is looking at the safety and performance of a new device called the Glean Urodynamics System. This system helps doctors understand how your bladder and urinary tract are working, both in the clinic and at home. You might be able to join if you are at least 22 years old, male or female, and your doctor thinks you need a urodynamics study (UDS) as part of your usual care. The main goal is to see how many people experience any problems with the Glean Urodynamics System up to 14 days after it's removed. The study is currently unclear on its recruitment status and plans to enroll about 101 participants.
- Study design
- This is an open-label, single-arm study, meaning all participants will receive the Glean Urodynamics System and everyone involved will know what treatment is being given. It aims to enroll about 101 participants.
- What's involved
- You will have the Glean Urodynamics System inserted for monitoring in the clinic, then wear it at home for up to 24 hours. The sensor will be removed within 24 hours, and you will provide a urine sample 7 days later.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will have a follow-up phone call 14 days after the sensor is removed.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Ambulatory Long Length URodynamics Evaluation
At a glance
Conditions
Where it's being run
7 sites across 6 statesStudy leadership
- Brittany Carter, DHSc, MPH · STUDY_DIRECTOR · Bright Uro
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Percentage of participants experiencing a qualifying adverse event attributable to the Glean Urodynamics SystemFrom enrollment to 14 days after device removal
Percentage of participants experiencing a qualifying adverse event attributable to the Glean Urodynamics System